Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
This study has been terminated.
( Recruitment stopped according to early stopping rule (by protocol) )
Study NCT00597116   Information provided by AstraZeneca
First Received: January 9, 2008   Last Updated: October 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial